Tart Cherry vs Melatonin: A Practical Beginner's Guide

About one in three American adults regularly sleeps less than seven hours, according to the CDC, and melatonin supplement use among US adults jumped from 0.4% to 2.1% between 1999 and 2018, per a JAMA research letter. Tart cherry juice has ridden the same wave and now sits in concentrate form in most US and UK supermarkets. The stakes are practical: pick the wrong option and you can spend weeks and real money on a tool built for a different sleep problem — or drink 30 grams of sugar a night you did not need.

What the evidence actually shows

Melatonin is a hormone the pineal gland releases about two hours before natural sleep onset. As a supplement it behaves less like a sedative and more like a timing signal. Its half-life is short — roughly 30 to 60 minutes — which is why timing matters more than dose. The American Academy of Sleep Medicine's 2017 clinical practice guideline recommended against melatonin for chronic insomnia, judging the evidence weak. A 2022 Cochrane review of melatonin for primary sleep disorders likewise found no significant improvement in sleep latency or total sleep time. Where melatonin does perform is circadian timing: jet lag, delayed sleep-wake phase disorder, and shift work.

Quality control is a separate problem. A 2017 analysis in the Journal of Clinical Sleep Medicine found the actual melatonin content of 31 supplements ranged from 83% below to 478% above the label claim, and 26% of samples contained serotonin. Many users also overshoot: doses above 5 mg add next-day grogginess without adding sleep, because the dose-response curve flattens early.

Tart cherry, almost always the Montmorency variety, works differently. It contains small amounts of natural melatonin — roughly 13 nanograms per gram — plus tryptophan and anthocyanins that may slow the enzymatic breakdown of tryptophan toward serotonin and melatonin. The trials are small but point one way. A 2010 study of 20 older adults with insomnia recorded about 17 extra minutes of nightly sleep and lower insomnia-severity scores. A 2012 trial in healthy adults reported roughly half an hour of additional sleep alongside higher urinary melatonin. A 2018 pilot in eight insomniacs found 84 more minutes of sleep per night after two weeks of 240 mL juice twice daily. Across studies, the range is 17 to 84 minutes.

Why it matters for your night

The two options solve different problems, and matching tool to problem is where beginners lose money.

• Circadian problem (jet lag, delayed sleep phase, shift work): low-dose melatonin, 0.5–1 mg. Take it 3–5 hours before your target bedtime to shift the clock, or 30–60 minutes before bed as a mild sleep cue.
• Trouble staying asleep, or a food-first preference: Montmorency concentrate, 30 mL twice daily (morning and evening), for at least seven days. Effects build over days, not minutes.

Costs diverge sharply. Generic melatonin runs roughly 5–30 cents per night in the US and Canada. Cherry concentrate costs about $1.50–3 per day; the full juice protocol (480 mL daily) can reach $4–8. Each 30 mL shot of concentrate carries roughly 20–25 g of fruit sugars, and a 240 mL glass of juice about 30 g — a real consideration for anyone managing blood glucose.

Availability differs by country. Melatonin is over the counter in the US and Canada, prescription-only in the UK, and pharmacist-only in Australia for adults 55 and over (2 mg prolonged-release). Tart cherry juice faces no such barriers anywhere.

Side effects are mild but real. Melatonin can cause headaches, morning grogginess, and vivid dreams, and it interacts with anticoagulants, anticonvulsants, and immunosuppressants. Tart cherry's sorbitol can cause bloating in sensitive guts.

The honest counterpoint

The strongest scientific objection to both is scale. The AASM guideline found melatonin's evidence too weak to endorse for insomnia, and the tart cherry trials involve 8 to 20 participants, run one to two weeks, and several received funding from the cherry industry. No large, independent, long-term randomized trial exists for either.

The fair response: small trials pointing in the same direction, with low risk and low cost, justify a short personal test — not a belief system. Neither replaces cognitive behavioral therapy for insomnia (CBT-I), which the American College of Physicians lists as the first-line treatment for chronic insomnia. Our opinion, labeled as such: use melatonin for timing problems, tart cherry for a gentle, food-based nudge toward longer sleep, and treat both as bridges while you fix behavior — light exposure, caffeine timing, a consistent wake time.

How to run a two-week self-test

Week 1

Pick one option only: melatonin 0.5–1 mg, 30–60 minutes before bed, or cherry concentrate 30 mL twice daily. Do not stack both — you will not know what worked.

Week 2

Keep a simple log: lights-out time, estimated sleep, morning grogginess on a 1–5 scale. Lower the melatonin dose if you feel groggy; dilute the cherry juice if your stomach complains. If neither helps after two weeks, stop spending and ask a clinician about CBT-I.

Bottom line: melatonin earns its place for clock problems, tart cherry for modest sleep-time gains without a hormone, and neither is a cure — the evidence does not support promising one.